A Phase II Trial of R115777 [tipifarnib] in Myelofibrosis With Myeloid Metaplasia (MMM).
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2013
At a glance
- Drugs Tipifarnib (Primary)
- Indications Essential thrombocythaemia; Myelofibrosis; Polycythaemia vera
- Focus Adverse reactions; Therapeutic Use
- 10 Jan 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jul 2007 New trial record.